Previous studies have also suggested that SNX16 exhibited alternative splicing in certain melanoma cell lines and could interact with 32 SNPs that are known risk factors for prostate cancer (Tao et al., 2012; Watahiki et al., 2004). Here, SNX16 is linked to prostate cancer.